Eli Lilly & Co. New York Stock Exchange
Open: $326 High: $330.85 Low: $322 Close: $329.71
Range: 2022-06-27 - 2022-06-28
Market: Open
Eli Lilly & Co. LILLY CORPORATE CTR https://www.lilly.com
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
  • CEO: David A. Ricks
  • Employees: 35,000
  • Sector: Healthcare
  • Industry: Drug Manufacturers
Latest Stocks Posts
Card image
Card image
Card image
LLY News
Latest news about the LLY